Warning!
Your browser does not support HTML5.
Display of the content may be incorrect. Please make sure that your browser supports HTML5 syntax.
Search for Small Molecules by SMILES, name, CAS, MFCD, ID, InChI Key
Search for Biologics by ID, Target name, CAS, Protein name, Gene ID, Clone ID, Source Organism
0
0.00 €
Currency
Home CSSS00160473610

Structure Info

Chemspace ID
CSSS00160473610 (In-Stock Screening Compounds)
MFCD
MFCD09952211
IUPAC Name
N-(3-chloro-4-fluorophenyl)-7-(²H₃)methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine
Mol formula
C22H24ClFN4O3
Mol weight
450 Da
Catalog Number(s)
AA008Y10, AE17248, AG008Y3S, AGN-PC-0WBLPK, CSC160473610, G13653, G304002, HY-50895S2, LN01293690, Y3295427

Properties

LogP
3.75
Heavy atoms count
31
Rotatable bond count
8
Number of rings
4
Carbon bond saturation, Fsp3
0.363
Polar surface area (Å)
69
Hydrogen bond acceptors count
7
Hydrogen bond donors count
1

SDS

Choose Language:

If you wish to request SDS before ordering, please contact us at [email protected]

C22H24ClFN4O3
Zoom the structure
CSSS00160473610
 

Items Overall 2 items from 2 suppliers

SupplierLead timeShips fromPurityPackPrice, €Qty
MedChemExpress10 daysUnited States
To:
901 mg564
Go to cartEnquire
Description: Names: Gefitinib-d3; Product Description: Gefitinib-d 3 (ZD1839-d3) is the deuterium labeled Gefitinib. Gefitinib (ZD1839) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib also induces autophagy. Gefitinib has antitumour activity; Target: Autophagy;EGFR;Isotope-Labeled Compounds; CAS: 1173976-40-3
MedChemExpress EU10 daysSweden
To:
901 mg594
Go to cartEnquire
Description: Names: Gefitinib-d3; Product Description: Gefitinib-d3 (ZD1839-d3) is the deuterium labeled Gefitinib. Gefitinib (ZD1839) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib also induces autophagy. Gefitinib has antitumour activity; Target: Autophagy;EGFR;Isotope-Labeled Compounds; CAS: 1173976-40-3
For a custom pack size or bulk
please drop us a line:Enquire